Abstract. Serum C-reactive protein (CRP) concentrations have been reported to be associated with body fat, especially visceral fat accumulation, but most studies up to now have been conducted on non-diabetic subjects. In this study, we investigated the association between the serum CRP concentrations and parameters of adiposity and insulin resistance in both Japanese type 2 diabetes patients and non-diabetic subjects. A total of 248 Japanese subjects (140 type 2 diabetes patients and 108 non-diabetic subjects) were enrolled for the study. The degree of insulin resistance was estimated by the homeostasis model assessment (HOMA-R) method. Fat accumulation was evaluated by measuring visceral and subcutaneous fat areas at the level of the umbilicus in abdominal CT scans. To assess hepatic fat content, the ratio of CT attenuation value of the liver to that of the spleen (L/S ratio) was calculated. Serum CRP was found to be significantly correlated with various indices of adiposity, including L/S ratio, visceral fat area (VFA), subcutaneous fat area (SFA), and HOMA-R, in both the diabetic patients and the non-diabetic subjects. After adjustment for five variables (age, gender, serum CRP, HbA1c, and smoking), serum CRP was still significantly correlated with L/S ratio, VFA, SFA, and HOMA-R in the diabetic patients. We also found that changes in serum CRP concentrations were correlated with changes in the VFA and SFA at 1 year after the baseline in 24 diabetic patients. We conclude that serum CRP may be closely related to the degree of liver steatosis and visceral fat accumulation in Japanese type 2 diabetes mellitus patients.
C-REACTIVE protein (CRP) is one of the major acute-phase proteins and is a marker of systemic inflammation. Elevated serum CRP has been shown to be a strong predictor of future cardiovascular events [1] [2] [3] [4] , therefore, elucidation of the mechanisms underlying the elevation of serum CRP levels in healthy subjects is important. It has been suggested that the insulin resistance syndrome may be associated with increased serum CRP levels and visceral obesity [5] [6] [7] . Correlations between serum CRP and body mass index (BMI) and waist circumference have also been shown [6] [7] [8] . Although waist circumference has been used as a crude measure of visceral obesity, direct measurement of the visceral and subcutaneous adipose tissue areas by computed tomography (CT) is currently considered to be a more precise method. In fact, an association has been shown between visceral adipose tissue accumulation and the insulin resistance syndrome [9, 10] . However, there are few reports on the relationship between serum CRP and visceral adipose tissue area as measured directly by CT. Moreover, no studies have been conducted on large numbers of subjects to determine the association between serum CRP and visceral and subcutaneous adipose tissue areas in diabetic patients. We were, therefore, prompted to explore the relationships between serum CRP concentrations and visceral and subcutaneous adipose tissue accumula-tion, as measured by CT, and the degree of insulin resistance in Japanese type 2 diabetes mellitus patients and non-diabetic subjects.
Materials and Methods

Subjects
We evaluated the clinical indicators in patients who were admitted to the Yokohama City University Hospital between 2003 to 2005. The study protocol was reviewed and approved by the Institutional Ethical Review Committee. Informed consent was obtained from all of the study subjects prior to the examinations. The study was carried out on 248 subjects admitted to the hospital for evaluation of elevated transaminase levels or fatty liver, or for stringent control of blood glucose levels. Of the total, 140 were diabetic patients, and the remaining 108 were non-diabetic subjects. For the purpose of this study, subjects who had not been diagnosed as having diabetes mellitus prior to the present admission, in whom the serum HbA1c level was less than 5.8%, were defined as non-diabetic subjects. Selection of the study subjects was restricted to men and postmenopausal women, in order to eliminate the influence of pregnancy or female hormone replacement therapy. Also, only subjects older than 20 years of age were selected, so as to reduce the possible confounding effects of growth and development on the study parameters. A total of 248 Japanese (127 men and 121 postmenopausal women aged 57.8 ± 13.9 years; BMI, 25.7 ± 4.6 kg/m 2 ; 140 type 2 diabetes mellitus patients and 108 non-diabetic subjects) subjects were evaluated. Persons with a history of alcohol intake of ≥20 gm/ day were excluded from the study. The proportion of subjects with a history of smoking was 26% in the diabetic group and 13% in the non-diabetic group. We have previously demonstrated an association between serum ferritin levels and VFA and SFA [11] . In addition to our primary study objective, we also examined whether changes in serum CRP concentrations (∆CRP) were associated with changes in the body composition as measured by changes in parameters such as L/S ratio, VFA, and SFA in the diabetic patients at 1 year after admission. So far, we have been able to follow up 24 patients with type 2 diabetes among our study subjects.
Blood sampling and biochemical assay
Blood samples were obtained from the study subjects before breakfast on the second day of hospitalization, for measurements of the plasma glucose and insulin levels. The degree of insulin resistance was calculated by the homeostasis model assessment for insulin resistance (HOMA-R), using the following formula: [fasting serum insulin (µU/ml) × fasting plasma glucose (mg/dl)/405]. However, the HOMA-R and measurement of the serum CRP concentration was performed only in the 128 subjects in whom the fasting plasma glucose was less than 170 mg/dl, because HOMA-R has been reported to be a suitable method for evaluating insulin resistance only in type 2 diabetes mellitus patients with fasting glucose levels of 170 mg/ dl or less [12] . Ono et al. reported that the results of HOMA-R were not significantly correlated with the insulin resistance in subjects with fasting plasma glucose levels of more than 200 mg/dl [12] .
Determination of the visceral and subcutaneous fat areas
The abdominal fat distribution in the study subjects was determined by CT conducted with the subjects in the supine position, in accordance with a previously described procedure [13] . The SFA and intra-abdominal VFA were measured at the level of the umbilicus in terms of the CT number, using a standardized method. In brief, a region of interest was defined in the subcutaneous fat layer by tracing its contour on each scan, and the attenuation range for fat tissue was measured in terms of the CT number (in Hounsfield units).
Assessment of the hepatic fat content
The degree of liver steatosis was measured by CT. Previous studies have shown a strong correlation between the CT attenuation values of the liver and the extent of fatty infiltration of the liver as measured by liver biopsy [14, 15] . The ratio of the CT attenuation value of the liver to that of the spleen (L/S ratio) has also been used for quantitative estimation of the hepatic fat content, with an L/S ratio of <1 being considered to represent fatty liver [14] .
Data analysis
All data were expressed as means ± SD. The relationship between any two variables was analyzed by standard correlation analysis conducted using the StatView, ver. 5.0, software (SAS, Cary, NC, USA). Analysis of variance was applied for group comparisons, followed by Student's t-test for confirmation of the statistical associations. The relationship between the L/S ratio, VFA or SFA and other relevant covariates was examined by multiple regression analysis and determination of the standardized correlation coefficients. Statistical significance was assumed when the p-value was <0.05.
Results
Relationship between e serum CRP concentrations and clinical parameters
The baseline characteristics of the 140 patients with type 2 diabetes mellitus and 108 non-diabetic subjects are shown in Table 1 . There were no significant differences in the serum CRP concentrations, VFA or SFA between the two groups (type 2 diabetes mellitus patients and non-diabetic subjects). The baseline characteristics of the 64 diabetic patients in whom the fasting plasma glucose was less than 170 mg/dl and the 64 non-diabetic subjects are shown in Table 2 . We did not calculate the HOMA-R in 44 non-diabetic patients, because of non-availability of the serum insulin values or sampling under non-fasting conditions. The correlations between the serum CRP concentrations and the other factors examined in this study are illustrated in Fig. 1 . Serum CRP was inversely correlated with L/S ratio (r = -0.275, p<0.0001) (Fig. 1A) ; in other words, it was positively correlated with the degree of liver steatosis. Serum CRP was also significantly correlated with VFA (r = 0.323, p<0.0001) (Fig. 1B) , and SFA (r = 0.319, p<0.0001) (Fig. 1C) . In the 64 non-diabetic subjects and 64 type 2 diabetes patients in whom the fasting plasma glucose levels were less than 170 mg/dl, serum CRP was significantly correlated with the degree of insulin resistance as measured by HOMA-R (r = 0.377, p<0.0001) (Fig. 1D) .
The presence of chronic metabolic and inflammatory diseases might confound the interpretation of elevated serum CRP levels in diabetic patients. Therefore, in this study, we excluded subjects with serum CRP concentrations of more than 0.5 mg/dl. We then examined the relationship between the serum CRP concentrations and other factors in the diabetic patients and nondiabetic subjects. Serum CRP was significantly correlated with L/S ratio (r = -0.314, p = 0.0003), VFA (r = 0.219, p = 0.0154), SFA (r = 0.283, p = 0.0015), and HOMA-R (r = 0.377, p = 0.0028) in the diabetic patients ( Fig. 2 ). In the non-diabetic subjects also, serum CRP concentration was significantly correlated with L/S ratio (r = -0.230, p = 0.0326), VFA (r = 0.548, p<0.0001), SFA (r = 0.395, p = 0.0002), and HOMA-R (r = 0.381, p = 0.0024) (Fig. 3) . Thus, serum CRP concentration was significantly correlated with L/S ratio, VFA, SFA, and HOMA-R in both the diabetic patients and the non-diabetic subjects. We further divided both the diabetic patients and the non-diabetic subjects into two subgroups based on their BMI [obese (BMI≥25) and non-obese (BMI<25)], and repeated the analyses separately in all four groups. Among the diabetic patients, serum CRP was closely correlated with the L/S ratio in patients with BMI<25, but not in those with BMI≥25 (Table 3) , and with VFA and SFA in patients with BMI≥25, but not in those with BMI<25. Among the non-diabetic subjects, serum CRP was significantly correlated with the VFA in subjects with BMI≥25, but not in those with BMI<25; there was no significant correlation between serum CRP with L/S ratio or SFA in the non-diabetic subjects, irrespective of BMI. Thus, serum CRP showed no significant correlation with VFA and SFA in the nonobese subjects (BMI<25) ( Table 3) , consistent with previous reports [7, 17] .
Multiple regression analysis
Multiple regression analysis was conducted to quantify the impact of the measured variables (age, gender, serum CRP, HbA1c, and smoking) on L/S ratio, VFA, SFA, and HOMA-R. The results, as shown in Table  4A , indicated that the age, serum HbA1c and serum CRP were significantly correlated with L/S ratio in both the diabetic and the non-diabetic groups. We then carried out multiple regression analysis separately in the diabetic patients and the non-diabetic subjects. Interestingly, while the serum CRP concentration was Relationship between serum CRP concentrations and level of insulin resistance as determined by HOMA-R method; there was a significant correlation (r = 0.377, p<0.0001). Analysis of the relationship between these two factors was performed in 64 diabetic patients and 64 non-diabetic subjects whose fasting plasma glucose levels were less than 170 mg/dl.
significantly correlated with the L/S ratio in the diabetic patients (Table 4B) , this correlation was not valid in the non-diabetic subjects (Table 4C ). As shown in Table 5 , the gender and serum CRP were significantly correlated with the VFA in both the diabetic and nondiabetic groups. As shown in Table 6 , serum CRP and serum HbA1c were significantly correlated with the SFA in both the diabetic and non-diabetic groups. Serum CRP and serum HbA1c were also significantly correlated with HOMA-R, as shown in Table 7 . Thus, even after adjustment for the five variables, serum CRP was still correlated significantly with VFA, SFA, L/S ratio, and HOMA-R in both the diabetic subjects and the entire subject population. We previously reported that serum ferritin was correlated with adiposity and insulin resistance [10] . To elucidate whether serum CRP or serum ferritin is more closely correlated with adiposity and insulin resistance, we conducted multiple regression analysis to quantify the impact of six measured variables (age, gender, serum CRP, serum ferritin, HbA1c, and smoking) on L/S ratio, VFA, SFA, and HOMA-R. After adjustment for the six variables, it was found that the serum CRP was more strongly correlated with L/S ratio, VFA, SFA, and HOMA-R in the entire subject population than serum ferritin (Table 8) . Thus, serum CRP appears to be more closely correlated with adiposity and insulin resistance than serum ferritin.
Analysis of the relationship between ∆CRP and ∆body composition in the diabetic patients at 1 year after admission
We next examined whether the changes in the serum CRP concentrations (∆CRP) were associated with changes in the body composition as measured by changes in parameters such as L/S ratio, VFA, and SFA in the diabetic patients. The characteristics of 24 patients with type 2 diabetes mellitus at baseline and at 1 year after admission are shown in Table 9 . Out of the 24 patients with type 2 diabetes, 5 showed a ≥20% reduction, and 14 showed a >20% increase in the serum CRP levels at 1 year after admission. We analyzed the relationship between the ∆CRP and the ∆ indices of body composition, such as the ∆L/S ratio, ∆VFA, and ∆SFA. The ∆CRP was significantly correlated with the ∆L/S ratio (r = -0.594, p = 0.0017), ∆VFA (r = 0.488, p = 0.0145), and ∆SFA (r = 0.489, p = 0.0142) (Fig. 4) . These results suggest that the serum CRP may be a clinically useful marker to assess the degree of liver steatosis and visceral and subcutaneous fat accumulation.
We further analyzed the relationship between ∆fer-ritin and the ∆ indices of body composition, such as ∆L/S ratio, ∆VFA, and ∆SFA in the 24 patients. The ∆ferritin was significantly correlated with ∆L/S ratio (r = -0.533, p = 0.0020), ∆VFA (r = 0.450, p = 0.0118), and ∆SFA (r = 0.423, p = 0.0191).
Discussion
In this study, we investigated the association between serum CRP concentrations and hepatic fat content, visceral fat area, subcutaneous fat area, and the degree of insulin resistance. We demonstrated that serum CRP was significantly correlated with VFA and SFA as estimated by abdominal CT in the diabetic patients (Fig. 2B, 2C ). We were also able to reproduce the previously reported association between serum CRP and hepatic fat content and degree of insulin resistance [16] (Fig. 1A, 1D , Table 4 ). We found that the association between the serum CRP and the L/S ratio was more significant in the diabetic patients than in the non-diabetic subjects (Table 4) . We further examined whether the changes in serum CRP concentrations were associated with changes in the L/S ratio, VFA, and SFA at 1 year after admission in patients with type 2 diabetes (Fig. 4) . Our results revealed that ∆CRP was significantly correlated with ∆L/S ratio, ∆VFA, and ∆SFA in these patients. Based upon the results of these cross-sectional and longitudinal studies, we concluded that serum CRP concentration might be closely related to the degree of liver steatosis and visceral and subcutaneous fat accumulation in patients with type 2 diabetes mellitus.
Saijo et al. reported an association between the serum CRP and visceral adipose tissue accumulation in healthy Japanese subjects. They demonstrated that the serum CRP was significantly associated with the VFA and SFA [18] . It should be noted, however, that in this study, the serum CRP concentrations were lower in healthy Japanese subjects (0.052 mg/dl: interquartile range, 0.023-0.090) than in the diabetic patients (0.097 ± 0.009) [18] . We now report an association between serum CRP concentration and hepatic fat content and visceral and subcutaneous adipose tissue accumulation in both Japanese patients with type 2 diabetes mellitus and non-diabetic subjects. To the best of our knowledge, this is the first study conducted to analyze the association between serum CRP concentration and visceral and subcutaneous adipose tissue accumulation in patients with type 2 diabetes mellitus. While the reasons for the association between serum CRP concentrations and the indices of adiposity are still not clear, several mechanisms have been proposed to explain this association. It has been reported that the circulating levels of tumor necrosis factor (TNF)-α are increased in obesity [19] , and that TNF-α can stimulate the production of CRP [20] . Circulating levels of interleukin (IL)-6, also induce the production of CRP [21] , and have been found to be elevated in obese individuals [22] . Because the synthesis of CRP by the liver is largely regulated by IL-6 [23] and because approxi- The dependent variable was the L/S ratio, and the independent variables were age, gender, serum CRP, serum HbA1c, and smoking. R 2 for the entire model = 0.953 The dependent variable was VFA, and the independent variables were age, gender, serum CRP, serum HbA1c, and smoking. R 2 for the entire model = 0.900 mately 30% of the total circulating concentrations of IL-6 originate from the adipose tissue in healthy subjects [24] , the aforementioned association is compatible with an adipose tissue origin of IL-6. It has been reported that the enhanced production of IL-6 from adipose tissue may be more closely related to the increase of the total body fat mass than to the overexpression of IL-6 in adipose tissue [25] . One in vitro study demonstrated that more IL-6 was released from the abdominal visceral adipose tissue than from the subcutaneous adipose tissue in humans [26] .
In conclusion, a direct correlation was demonstrated between serum CRP concentrations and the VFA and SFA as estimated by CT in patients with type 2 diabetes mellitus. Measurement of serum CRP may, therefore, be a highly useful, non-invasive, and cost The dependent variable was SFA, and the independent variables were age, gender, serum CRP, serum HbA1c, and smoking. R 2 for the entire model = 0.911 The dependent variable was HOMA-R, and the independent variables were age, gender, serum CRP, serum HbA1c, and smoking. R 2 for the entire model = 0.867
effective method for assessment of fat distribution and degree of insulin resistance in patients with type 2 diabetes mellitus. The dependent variable was VFA, and the independent variables were age, gender, serum CRP, serum ferritin, serum HbA1c, and smoking. R 2 for the entire model = 0.821
The dependent variable was HOMA-R, and the independent variables were age, gender, serum CRP, serum ferritin, serum HbA1c, and smoking. R 2 for the entire model = 0.834 Table 9 . Characteristics of the 24 patients with type 2 diabetes mellitus at the baseline and at 1 year after admission ∆CRP > 20% (n = 14) -20% < ∆CRP ≤ 20% (n = 5) ∆CRP ≤ -20% (n = 5) baseline 1 year after admission baseline 1 year after admission baseline 1 year after admission
